JSC

Pharmstandard is the leading pharmaceutical company in Russia, specializing in the development, manufacture, and marketing of a wide range of high-quality pharmaceutical products. The company operates multiple manufacturing facilities that comply with international GMP standards, producing over 440 distinct products across various therapeutic areas including oncology, cardiology, and endocrinology. Pharmstandard is a key player in the Russian government's import substitution program and maintains significant partnerships with global pharmaceutical leaders for localized production. Its portfolio includes well-known brands such as Arbidol, Pentalgin, and Complivit, alongside a growing pipeline of biosimilars and innovative biologics.